Independent Director · Lineage Cell Therapeutics, Inc. (LCTX)

Angus C. Russell director compensation at Lineage Cell: $121K

Fiscal year 2025 director compensation for Angus C. Russell at Lineage Cell Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Angus C. Russell’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Angus C. Russell and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Lineage Cell Therapeutics Director Compensation Table · all 4 fiscal years held
In US dollars, as Lineage Cell Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$75,000$0$45,990$0$120,990
FY2024$71,250—$71,558—$142,808
FY2023$67,500—$70,500—$138,000
FY2021$57,500—$89,555—$147,055

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Lineage Cell Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191556, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Lineage Cell Therapeutics, Inc. filed document, accession 0001193125-26-191556. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Get the Lineage Cell Therapeutics Board Governance Report

$120,990 Angus C. Russell, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Lineage Cell Therapeutics pays directors a $50,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit

The rest of the Lineage Cell Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Anula JayasuriyaIndependent Director$103,490
Brian M. CulleyDirector—
Deborah AndrewsIndependent Director$123,490
Dipti AminIndependent Director$103,490
Michael H. MulroyIndependent Director$160,990
Neal C. BradsherIndependent Director$118,490

The full Lineage Cell Therapeutics compensation record

free company brief

This page is one director within Lineage Cell Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Lineage Cell Therapeutics proxy · each links to its own free brief

Order LCTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report